.
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
https://grassfed.us/James-sister-of-Ploof-from-Incheon
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.